VenDd in t(11;14) RR MM
Phase I/II Trial of Venetoclax/Dara/Dex (VenDd) vs Bortezomib/Dara/Dex (DVd) in t(11;14) R/R MM: Updated Analysis of MRD Negativity

Released: December 11, 2023

Activity

Progress
1
Course Completed